Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
1.
Annals of the Academy of Medicine, Singapore ; : 225-231, 2014.
Article Dans Anglais | WPRIM | ID: wpr-285519

Résumé

<p><b>INTRODUCTION</b>Superovulation-intrauterine insemination (SO-IUI) is the most common assisted reproductive technique (ART) in the world, with good evidence of efficacy and cost-effectiveness. However, parameters affecting its success have not been consistently reported. So in this study, we aim at determining the parameters influencing the success rate of SO-IUI.</p><p><b>MATERIALS AND METHODS</b>We conducted a retrospective cohort study of 797 SO-IUI cycles from 606 patients, performed between 2007 and 2009 in a single centre. These women received clomiphene citrate (CC), recombinant FSH (rFSH) or both.</p><p><b>RESULTS</b>There were 127 clinical pregnancies with a pregnancy rate (PR) of 15.9% (127/797) per treatment cycle. Factors associated with higher PR included maternal age <38 (P = 0.02), subfertility diagnoses of ovulatory disorders, unexplained infertility, sexual dysfunction and unilateral tubal obstruction (P = 0.02), an endometrial thickness ≥8 mm (P = 0.03), total number motile spermatozoa (TNMS) of ≥1 million (P = 0.03), and spermatozoa normal forms (NF) ≥4% (P <0.01) on bivariate analysis. When CC is used, the endometrial thickness is more likely to be suboptimal (<8 mm). All the above parameters remained significant except the subfertility diagnoses on multivariate analysis.</p><p><b>CONCLUSION</b>Patients' selection with women <38 years old and preferably with ovulation disorders and unexplained infertility is associated with the highest PR in SO-IUI. Cycle parameters such as the use of rFSH alone, with the avoidance of CC, TNMS ≥1 million and NF ≥4% is likely to result in the best outcomes and reduce the high order multiple pregnancy risk.</p>


Sujets)
Adulte , Femelle , Humains , Grossesse , Facteurs âges , Clomifène , Utilisations thérapeutiques , Études de cohortes , Fécondostimulants féminins , Utilisations thérapeutiques , Infertilité féminine , Insémination artificielle , Méthodes , Taux de grossesse , Pronostic , Études rétrospectives , Superovulation
SÉLECTION CITATIONS
Détails de la recherche